Doctors at Evelina Children's Hospital in London have invented one of Europe's top-selling medical iPhone applications, with more than 100 downloads every week. The Paediatric Emergency Drugs app enables medical and nursing staff to quickly work out complicated drug calculations during emergencies to ensure paediatric patients receive the correct drug doses for their age and weight. Paediatric intensive care consultant, Dr Shelley Riphagen, came up with the idea with the help of Dr Andrew Durward's IT skills and the app went on sale in March this year. Dr Riphagen said: "When critically-ill children present to district general hospitals with emergencies, the right doses of drugs according to the child's age and weight need to be available immediately. The Paediatric Emergency Drugs app allows this to happen. It has made a huge difference to the care of our patients and it's really fantastic to know that it's also appreciated by medical and nursing staff in hospitals across Europe." The project was made possible through collaboration with UBQO.
Medical app is best seller
You may also like
Manufacturing
What makes a GMP quality system effective in day-to-day pharmaceutical manufacturing?
Read moreYour quality system may have a procedure for almost everything: reporting a deviation, reviewing a batch record, changing equipment settings and training the people who operate it. But having a procedure and getting a useful answer from it are two different things
Trending Articles
-
You need to be a subscriber to read this article.
Click here to find out more.
You may also like
Manufacturing
What makes a GMP quality system effective in day-to-day pharmaceutical manufacturing?
Your quality system may have a procedure for almost everything: reporting a deviation, reviewing a batch record, changing equipment settings and training the people who operate it. But having a procedure and getting a useful answer from it are two different things
Regulatory
Pheno Therapeutics secures two patents for neurological drug pipeline
The Edinburgh-based biotech has strengthened its intellectual property portfolio for two selective GPR17 antagonists, including its lead multiple sclerosis candidate, PTD802, which has US and UK regulatory clearance to enter clinical trials
Cleaning
Guardtech partner with Intense Pulsed Light innovators Biopulz to offer game-changing new cleanroom decontamination solution
New partnership will give Guardtech clients access to Biopulz’s mobile Eloane tower and integrated E-z̈o IPL decontamination system as part of their cleanroom installation projects
Analysis
Inspection readiness should be part of normal operations
For routine surveillance inspections, readiness cannot depend on receiving advance notice. Inspection readiness should be embedded in everyday operations, while recognising that preparation may need to become more intensive ahead of a known regulatory milestone